← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2019-10-08

Drug application

FDA Application #

ANDA206912

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

PREGABALIN

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2019-10-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown